Parkinson’s Disease :: FDA approves Neupro Patch for treatment of early Parkinson’s disease
The U.S. Food and Drug Administration (FDA) announced the approval of Neupro (rotigotine transdermal system), a skin patch designed to treat symptoms of early Parkinson’s disease.